Influenza vaccine: FDA approves Flucelvax Quadrivalent for children as young as six months old

By NewsDesk @bactiman63 Seqirus announced Friday that the U.S. Food and Drug Administration (FDA) has approved FLUCELVAX(R) QUADRIVALENT (Influenza Vaccine), the company's cell-based quadrivalent influenza vaccine, for an expanded age indication for children as young as six months old. With this approval, FLUCELVAX QUADRIVALENT, the first and only cell-based influenza vaccine in the U.S., is now [...]

The post Influenza vaccine: FDA approves Flucelvax Quadrivalent for children as young as six months old appeared first on Outbreak News Today.